Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
pharmaphorum
48m
J&J's Spravato gets another lift with new FDA approval
The accelerating sales growth of Johnson & Johnson's Spravato could go up yet another gear after the FDA approved a third ...
Hosted on MSN
29m
FDA Clears Spravato For Monotherapy Depression Treatments
The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...
pharmaphorum
41m
HPV self-collection: A step closer to eliminating cervical cancer
Cervical cancer is often highly treatable, with a five-year relative survival rate of 91% for localised, early-stage disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Prince Harry settles suit
Los Angeles wildfire updates
California fires: How to help
Murder charge upheld
Turns down plea deal
Faces new allegations
The Band's keyboardist dies
Bryan pastor found guilty
Can target schools, churches
1st Japanese elected to HOF
Silk Road founder pardoned
Birthright citizenship suit
SCOTUS grants new hearing
Wildfires near San Diego
Meta ex-COO sanctioned
Israel raids West Bank
'Days of Our Lives' star dies
Voice of Navy football dies
Raising prices again
FDA approves nasal spray
Trailblazing cartoonist dies
Coast Guard chief fired
Doug Collins hearing
Antisemitism lawsuits settled
Discuss strengthening ties
Judge blocks report release
Israel’s top general resigns
Released from prison
Related topics
Johnson & Johnson
United States
Ketamine
Food and Drug Administration
depression
Feedback